Relative dose intensity of taxane-based chemotherapy in breast cancer patients in a tertiary hospital.
Amira M HelwaniYousuf M Al SuleimaniKhalid Al BaimaniAly M AbdelrahmanPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
An optimal RDI greater than 85% was achieved in most cases. Furthermore, prophylactic and therapeutic supportive measures were widely used.